Cancer Center Uzbekistan will NEVER ask you to transfer money over a call. Pay only at the cashier and always take a receipt. If in doubt, call the 24/7 helpline at 1303. Fighting corruption →

Medical Oncologist

Kamila Izrailbekova

Pharmacological Treatment of Malignant Tumors (Chemotherapy, Targeted Therapy, Immunotherapy)

Professional summary

Dr. Kamila Izrailbekova is a medical oncologist specialising in the pharmacological treatment of malignant tumours, including chemotherapy, targeted therapy, and immunotherapy. She holds a PhD in Oncology and brings extensive clinical experience in managing complex cancer cases. Dr. Izrailbekova serves as principal investigator on several international clinical trials and is an active contributor to the scientific literature in her field.

Areas of expertise

  • Diagnosis and treatment of gastric, intestinal, and pancreatic cancers and other gastrointestinal tumors
  • Chemotherapy
  • Targeted therapy
  • Immunotherapy
  • Contemporary pharmacological treatment of oncological diseases

Education & training

Tashkent Medical Academy, Medical and Pedagogical Faculty (2005–2012)

Master's degree (clinical residency) in Oncology, National Oncology Center of Uzbekistan (2012–2014)

Specialization in Chemotherapy, Center for the Development of Professional Qualifications of Medical Workers

Internship at N.N. Petrov National Medical Research Center of Oncology, Saint Petersburg, Russia (2019)

Internship at Myongji Hospital, Republic of Korea (2022)

Certifications & licenses

Certificate in the specialty of Chemotherapy, Center for the Development of Professional Qualifications of Medical Workers

Oncology Specialist Certificate

Achievements & research

PhD in Oncology; author of more than 35 scientific publications and 60 abstracts on modern approaches to pharmacological oncology treatment

Regular speaker at international oncology congresses and conferences

Principal Investigator of a clinical trial evaluating the efficacy and safety of the Lily device for prevention of chemotherapy-induced alopecia

Principal Investigator of the international Luminate clinical trial on ablative treatment methods for pain control in patients with pancreatic cancer

2nd place at the IX Congress of Oncologists and Radiologists of Kazakhstan (2023)

Medical information notice

Website information supports patient orientation only. It does not replace consultation, diagnosis, treatment decisions, or emergency care from qualified medical staff.

Contacts
Feedback

We use cookies

Some cookies are required to run this site securely. With your permission, we would also like to use analytics cookies to understand how the site is used and improve it. You can accept or decline, and change your choice at any time. For more details, see our Cookie Policy.